Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hochman, US

Daryl W. Hochman, Bahama, NC US

Patent application numberDescriptionPublished
20090215754METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS - The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount, inactivating, and/or inhibiting the activity of a Na08-27-2009
20090258844COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS - The present invention relates to methods and compositions for treating selected conditions of the central and peripheral nervous systems employing non-synaptic mechanisms. More specifically, one aspect of the present invention relates to methods and materials for treating seizure and seizure disorders, epilepsy, status epilepticus, migraine, spreading depression, intracranial hypertension; for treating the pathophysiological effects of head trauma, stroke, ischemia and hypoxia; for treating or protecting from the pathophysiological effects of neurotoxic agents such as ethanol; and for treating neuropsychiatric disorders and central nervous system edema by administering agents that modulate ionic concentrations and/or ionic gradients in the brain, particularly ion-dependent or cation-chloride cotransporter antagonists. Electrolyte cotransport antagonists and combinations of such compositions with other agents for treating various conditions are disclosed.10-15-2009

Patent applications by Daryl W. Hochman, Bahama, NC US

George Hochman, Charlotte, NC US

Patent application numberDescriptionPublished
20100200107DIESEL EXHAUST FLUID STORAGE AND DISPENSING SYSTEMS - A liquid storage and dispensing system for storing and dispensing diesel exhaust fluid to a vehicle. The system includes a diesel exhaust fluid storage tank surrounded by a housing in which the interior temperature is maintained above a first temperature at or below which salting of the fluid occurs, and below a second temperature at or above which an ammonia constituent of the fluid evaporates. The system further includes filling and dispensing systems for refilling the storage tank and dispensing the fluid.08-12-2010

Jeremy Hochman, Austin, TX US

Patent application numberDescriptionPublished
20100135032Rod Assembly Connector for Mounting Light Emitting Display Apparatuses - A method and system for connecting a light emitting apparatus is disclosed herein. The system includes at least two rod assembly connectors, in which each rod assembly connector includes a rod assembly body having a first end and a second end. The first end of one of the rod assembly connectors is configured to connect with the second end of the second rod assembly connector. Further, at least one of the rod assembly connectors includes an attachment mechanism, in which the attachment mechanism is configured to attach to a light emitting apparatus.06-03-2010
20110103050360 Degree Viewable Light Emitting Apparatus - A light emitting apparatus and method of manufacturing thereof are disclosed. The light emitting apparatus includes a plurality of printed circuit boards connected to one another, a light emitting element disposed on and electrically connected to each printed circuit board, and at least one connector disposed between the printed circuit boards. The method of manufacturing the light emitting apparatus includes disposing a light emitting element on a plurality of printed circuit boards, arranging planar surfaces of the plurality of printed circuit boards substantially opposite, and connecting the plurality of printed circuit boards to one another.05-05-2011

Patent applications by Jeremy Hochman, Austin, TX US

Jeremy R. Hochman, Austin, TX US

Patent application numberDescriptionPublished
20080244943Variable Baffle for Low Resolution Displays - A display system comprising a substrate, a first light emitting element mounted on the substrate, a second light emitting element mounted on the substrate adjacent to the first light emitting element, and a baffle disposed between the first light emitting element and the second light emitting element.10-09-2008
20080247727System for creating content for video based illumination systems - A method for generating lighting includes selecting a video clip from a database of generic video clips, processing at least a portion of the video clip to create a customized video clip, sending the customized video clip to a light emitting array, and generating lighting from the light emitting array based on the customized video clip.10-09-2008
20100090927Ladder Display System - A system and a method for creating a light emitting apparatus are disclosed herein. The light emitting apparatus includes at least one display module having at least one light emitting element, in which the display module is connected between one of a support and a support bar at one end and another of a support and a support bar at the other end. The display module may then be electrically connected to another display module and be configured to emit light using the light emitting element.04-15-2010

Joel S. Hochman, Houston, TX US

Patent application numberDescriptionPublished
20100004707System and Method For Transducing, Sensing, or Affecting Vaginal or Body Conditions, and/or Stimulating Perineal Musculature and Nerves using 2-Way Wireless Communications - A system for sensing vaginal conditions or for affecting vaginal or body conditions in a mammal. The system includes a portable probe unit and a separate controller unit, both of which include two-way communication devices to both transmit signals to, and receive signals from, each other, wirelessly and in real time. The substantially smooth and sealed outer surface of the cylindrical body of the probe unit has a rounded end and is dimensioned to permit comfortable and repeated insertion into, removal from, and containment entirely within a mammal's vagina. The probe body has a device substantially flush with its outer surface and configured to deliver electrical pulses, receive electrical pulses, sense or sample vaginal conditions and/or deliver medication. Signals to the probe unit comprise control and programming signals acting as a feedback loop configured to start, stop and/or alter activity of the substantially flush device of the probe unit, either automatically or manually, for sensing vaginal conditions or for affecting vaginal or body conditions.01-07-2010

Mark Hochman, Lake Success, NY US

Patent application numberDescriptionPublished
20080281265Handpiece For Fluid Administration Apparatus - A handpiece assembly is provided that is adapted for use with a medication infusion system that applies pressure to the handpiece assembly for delivering medication to a body. The handpiece assembly includes a cartridge holder that is configured for disposal of a medication cartridge. A tubing is provided having a first end, which is sealed with the cartridge holder such that the cartridge holder facilitates communication between the tubing and the medication cartridge. A handpiece is sealed with a needle and the second end of the tubing so that the tubing and the needle are in communication. One of the cartridge holder, the tubing, the needle or the handpiece is configured for a selective structural failure at a predetermined pressure threshold applied to the handpiece assembly from the medication infusion system. The cartridge holder may be designed to facilitate aspiration.11-13-2008
20100221681METHOD AND APPARATUS FOR PERISTALTIC PUMP AND SURGICAL HANDPIECE WITH PRESSURE REGULATED FLUID SENSING FOR MAXILLARY SINUS ELEVATION - An apparatus for performing a maxillary sinus membrane elevation is described having a peristaltic or other electronic pump providing a fluid to a sleeve extending to the maxillary sinus through a handle. A pressure sensor monitors the fluid pressure and if the pressure reaches an excessive pressure level, the fluid flow is cut off to protect the membrane. Pressure variations in the fluid pressure due to the operation of the pump are reduced or eliminated using one or more baffles.09-02-2010

Patent applications by Mark Hochman, Lake Success, NY US

Mark N. Hochman, Lake Success, NY US

Patent application numberDescriptionPublished
20080213729METHOD AND APPARATUS FOR PERFORMING MAXILLARY SINUS ELEVATION - A method and apparatus is disclosed for providing implants in the upper jaws of a person. A sleeve is inserted through the alveolar ridge to the maxillary sinus. The sleeve is used to raise the subantral membrane and form a cavity. A filler, such as a bone growth stimulant is injected through the sleeve into the cavity. In the process, the sleeve also can cut and/or condense the bone around itself so that the bone can hold an implant. Optionally, the bone growth stimulant is also introduced into the bone surrounding the sleeve. During the injection, the pressure within the sleeve or the cavity is monitored to detect and prevent the rupture of the subantral membrane.09-04-2008

Patent applications by Mark N. Hochman, Lake Success, NY US

Mark N. Hochman, Great Neck, NY US

Patent application numberDescriptionPublished
20090030366SELF-ADMINISTRATION INJECTION SYSTEM - Self-injection system allows a user to inject a drug from a cartridge carrying unique identification information, into any one of a plurality of injection sites. Tissue at each injection site is associated with at least one injection parameter, such as flow-rate, that is different for each site. A scanner reads the identification information of the cartridge and cooperates with a central processing unit to determine the validity of the drug in order to permit an injection procedure to commence. The central processing unit has a memory for storing the different injection parameters and controls a drive unit for driving fluid from the cartridge and through a needle into the selected tissue, at the injection parameter that is associated with the user selected tissue for the injection.01-29-2009
20090326482Computer Controlled Drug Delivery System with Dynamic Pressure Sensing - Apparatus administers dental anesthetic to intraligamentary tissue with a drive unit and handpiece with injection needle connected by flexible tube to the unit. The drug is passes to the tissue at an instantaneous pressure at the needle tip that varies due to placement. A minimum threshold pressure is desired for administering the drug to the tissue. A practitioner moves the handpiece to insert the needle tip near the intraligamentary tissue and the instantaneous pressure is sensing or calculating. An auditory ascending signal indicates when the instantaneous pressure is rising, and when the instantaneous pressure reaches the threshold pressure a perceptible auditory specific signal indicates the practitioner has moved the tip into intraligamentary tissue. The tip is then maintained for supplying a selected dosage of the drug. Another auditory signal notifies the practitioner that the instantaneous pressure is declining or fluctuating before reaching the minimum threshold pressure.12-31-2009

Patent applications by Mark N. Hochman, Great Neck, NY US

Matias G. Hochman, Philadelphia, PA US

Patent application numberDescriptionPublished
20100204589NON-INVASIVE INTRACRANIAL PRESSURE SENSOR - A system and method for non-invasively detecting intracranial pressure (ICP) of a living being by detecting impedance mismatches between carotid arteries and cerebral vessels via a reflection of the carotid pressure waveform using a pressure sensor positioned against the palpable carotid artery, as well as analyzing the reflection and comparing the analysis with known cerebral vasculature data, to calculate ICP non-invasively. A remote blood pressure waveform can also be used to compensate for blood system impedance.08-12-2010

Paula Hochman, Newton, MA US

Patent application numberDescriptionPublished
20090104150Polymer conjugates of interferon Beta-1a and uses - An interferon beta polypeptide comprising interferon-beta 1a coupled to a polymer containing a polyalkylene glycol moiety wherein the interferon-beta-1a and the polyalkylene glycol moiety are arranged such that the interferon-beta-1a has an enhanced activity relative to another therapeutic form of interferon beta (interferon-beta-1b) and exhibits no decrease in activity as compared to non-conjugated interferon-beta-1a. The conjugates of the invention are usefully employed in therapeutic as well as non-therapeutic, e.g., diagnostic, applications.04-23-2009
20090286958INTERFERON-BETA FUSION PROTEINS AND USES - A fusion polypeptide is described having the amino acid sequence X-Y-Z, or portion thereof, comprising the amino acid sequence of a glycosylated interferon-beta (X); Y is an optional linker moiety; and Z is a polypeptide comprising at least a portion of a polypeptide other than glycosylated interferon-beta. It is preferred that X is human interferon-beta-1a. Mutants of interferon-beta-1a are also described.11-19-2009

Patent applications by Paula Hochman, Newton, MA US

Paula S. Hochman, Brookline, MA US

Patent application numberDescriptionPublished
20080219967Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases - Compositions and methods comprising “lymphotoxin-β receptor blocking agents” which block lymphotoxin-β receptor signaling and are useful for altering immunological diseases, and particularly antibody mediated immune responses.09-11-2008

Paula S. Hochman, Newton, MA US

Patent application numberDescriptionPublished
20110046073SOLUBLE LYMPHOTOXIN-BETA RECEPTOR FUSION PROTEIN AND METHODS FOR INHIBITING LYMPHOTOXIN BETA-RECEPTOR SIGNALING - This invention relates to compositions and methods comprising “lymphotoxin-β-receptor blocking agents”, which block lymphotoxin-β receptor signalling. Lymphotoxin-β receptor blocking agents are useful for treating lymphocyte-mediated immunological diseases, and more particularly, for inhibiting Th1 cell-mediated immune responses. This invention relates to soluble forms of the lymphotoxin-β.receptor extracellular domain that act as lymphotoxin-β receptor blocking agents. This invention also relates to the use of antibodies directed against either the lymphotoxin-β.receptor or its ligand, surface lymphotoxin, that act as lymphotoxin-β receptor blocking agents. A novel screening method for selecting soluble receptors, antibodies and other agents that block LT-β receptor signalling is provided.02-24-2011